Bradanicline
Bradanicline is a highly selective α7 nicotinic acetylcholine receptor (nAChR) agonist (humanα7 nAChR: EC50=17 nM; Ki= 1.4 nM) . Bradanicline is used for the research of cognitive disorders[1][2].
Product Specifications
CAS Number
639489-84-2
Product Name Alternative
TC-5619
UNSPSC
12352005
Target
NAChR
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/bradanicline.html
Purity
98.51
Solubility
DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C1=CC2=CC=CC=C2O1)N[C@H]3[C@H](CC4=CC=CN=C4)N5CCC3CC5
Molecular Formula
C22H23N3O2
Molecular Weight
361.44
References & Citations
[1]Mazurov AA, et al. Discovery of (2S,3R) -N-[2- (pyridin-3-ylmethyl) -1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a selective α7 nicotinic acetylcholine receptor agonist, for the treatment of cognitive disorders. J Med Chem. 2012;55 (22) :9793-9809. |[2]Hauser TA, et al. TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia. Biochem Pharmacol. 2009;78 (7) :803-812.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC683529-100 1x 100 µL
CD31 / PECAM-1 (Endothelial Cell Marker) (PECAM1/3529), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
